Thoracoabdominal Aortic Aneurysm Repair in Patients with Marfan Syndrome  by Mommertz, G. et al.
Eur J Vasc Endovasc Surg 35, 181e186 (2008)
doi:10.1016/j.ejvs.2007.10.013, available online at http://www.sciencedirect.com onThoracoabdominal Aortic Aneurysm Repair in Patients
with Marfan Syndrome*
G. Mommertz,1 F. Sigala,1 S. Langer,1 T.A. Koeppel,1 W.H. Mess,3
G.W.H. Schurink2 and M.J. Jacobs1,2*
European Vascular Center Aachen-Maastricht, 1Department of Vascular Surgery,
University Hospital Aachen and Maastricht, Germany, Departments of 2Vascular Surgery, and
3Neurophysiology, University Hospital Maastricht, The Netherlands* Pre
Spain,
*Corre
Surger
Maastr
E-mail
1078–5Objective.We assessed the surgical outcome of descending thoracic aortic aneurysm repair (DTAA) and thoracoabdominal
aortic aneurym (TAAA) repair in patients with Marfan syndrome.
Methods. During a six year period, 206 patients underwent DTAA and TAAA repair. In 22 patients, Marfan syndrome
was confirmed. The median age was 40 years with a range between 18 and 57 years. The extend of the aneurysms included
6 DTAA (1 with total arch, 2 with distal hemi-arch), 11 type II TAAA (2 with total arch, 3 with distal hemi-arch), 4 type
III and one type IV TAAA. All patients suffered from previous type A (n¼ 6) or type B (n¼ 16) aortic dissection and 15
already underwent aortic procedures like Bentall (n¼ 7) and ascending aortic replacement (n¼ 8). All patients were op-
erated on according to the standard protocol with cerebrospinal fluid drainage, distal aortic and selective organ perfusion
and monitoring motor evoked potentials. In patients undergoing simultaneous arch replacement (via left thoracotomy),
transcranial Doppler and EEG assessed cerebral physiology during antegrade brain perfusion. In four patients circulatory
arrest under moderate hypothermia was required.
Results. In-hospital mortality did not occur. Major postoperative complications like paraplegia, renal failure, stroke and
myocardial infarction were not encountered. Mean pre-operative creatinine level was 125 mmol/L, which peaked to a mean
maximal level of 130 and returned to 92 mmol/L at discharge. Median intubation time was 1.5 days (range 0.33e30 days).
Other complications included bleeding requiring surgical intervention (n¼ 1), arrhythmia (n¼ 2), pneumonia (n¼ 2) and
respiratory distress syndrome (n¼ 1). At a median follow-up of 38 months all patients were alive. Using CT surveillance,
new or false aneurysms were not detected, except in one patient who developed a visceral patch aneurysm six years after
open type II repair.
Conclusion. Surgical repair of descending and thoracoabdominal aortic aneurysms provides excellent short- and mid-term
results in patients with Marfan syndrome. In this series, a surgical protocol with cerebrospinal fluid drainage, distal aortic
and selective organ perfusion and monitoring motor evoked potentials resulted in low morbidity and absent mortality.
These outcomes of open surgery should be considered when discussing endovascular aneurysm repair in Marfan patients.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Marfan syndrome is a systemic disorder of connective
tissue caused by mutations in the extracellular matrix
protein fibrillin 11 and was first described in 1887 bysented at the XXI Annual meeting of the ESVS, Madrid,
September 20e23, 2007.
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diatrics. The incidence of classic Marfan syndrome is
about 2e3 per 10000 individuals; Gray reported the
incidence in Scotland as one in 9802 livebirths.2 Man-
ifestations of Marfan syndrome can be found in the
ocular, skeletal and cardiovascular system whereas
the cardiovascular pathology is the leading cause of
mortality and morbidity.3 The majority of fatal events
associated with untreated Marfan syndrome occur in
early adult life; the average age at death is estimated
to be 32 years.4 Early diagnosis and advances in med-
ical and surgical management since the seventiesr Surgery. Published by Elsevier Ltd. All rights reserved.
182 G. Mommertz et al.however, have greatly improved live expectancy, espe-
cially in case of aortic dissection and aneurysms.5e7
The cardiovascular complications of Marfan syn-
drome lead to a reduced life expectancy in affected
individuals if left untreated.4 Therefore medical
management has a significant role, including long-
term treatment with beta-adrenergic blockers which
has been shown to reduce the rate of aortic dilatation
and the frequency of aortic complications in a prospec-
tive study.8
Typically, the initial cardiovascular procedures in
Marfan patients concern the aortic root or ascending
aorta due to dilatation or type A dissection. Remain-
ing dissection in the aortic arch and/or descending
and thoracoabdominal aorta may eventually lead to
aneurysm formation, prompting the need for routine
imaging of the entire aorta.9
Elective prophylactic replacement of the involved
aortic segment is recommended in case of rapid diam-
eter increase (>0.5 to 1.0 cm/year), if symptoms occur,
when the aortic diameter reaches 5.0 to 6.0 cm, or
when the aortic diameter exceeds twice the diameter
of the normal aorta.9 At present, elective surgical re-
placement of the descending and thoracoabdominal
aorta in patients with Marfan syndrome is a safe pro-
cedure in experienced centers, however, significant
risks of death, paraplegia and renal failure remain
a matter of concern.10
Since the introduction of endovascular repair of
thoracic aneurysms, this modality has gained in-
creased interest, mainly because of its significant lesser
surgical trauma. Distinct fear concerns the interaction
of the stentgraft with the fragile aortic wall in Marfan
patients. Furthermore, Marfan patients are (relatively)
young and the question arises whether this technology
in thoracoabdominal aortic repair is advisable in these
patients. We therefore analyzed the clinical outcome of
open thoracic and thoracoabdominal aortic repair in
patients suffering from Marfan syndrome and as-
sessed short- and mid term survival.Table 1. Extension of aneurysms in patients with confirmed
Marfan Syndrome
Number of
patients
Involvement
of total
aortic arch
Involvement of
distal aortic
hemi-arch
DTAA 6 1 2
TAAA type II 11 2 3
TAAA type III 4
TAAA type IV 1
Total 22 3 5
DTAA¼Descending thoracic aortic aneurysm.
TAAA¼Thoracoabdominal aortic aneurysm.Patients and Methods
During a six year period, 206 consecutive patients un-
derwent descending thoracic aortic aneurysm repair
(DTAA) and thoracoabdominal aortic aneurysm
(TAAA) repair. In 22 patients, Marfan syndrome was
confirmed genetically and/or by means of histological
examination. All data were available and collected
retrospectively. All patients who were alive were
seen in the outpatient clinic in on annual base.
Themedianageof these22patientswas40yearswith
a range between 18 and 57 years. Six patients sufferedEur J Vasc Endovasc Surg Vol 35, February 2008from DTAA: in one patient the total aortic arch and in
two patients the distal hemi-archwas involved. The lat-
ter indicated that the left carotid artery and left subcla-
vian artery were engaged in the aneurysm, requiring
cross clamping between the brachiocephalic artery
and left carotid artery. For the thoracoabdominal aortic
aneurysms the Crawford classification was used to de-
scribe the extent of the aneurysm; eleven had type II
TAAA (two with associated total arch aneurysm and
three with distal hemi-arch aneurysm). Four patients
had type III and one type IV TAAA (Table 1). The
mean maximal diameter of the aneurysms was 5.8 cm
(range 4.8e10 cm). All patients suffered from previous
type A (n¼ 6) or type B (n¼ 16) aortic dissection and
15 already underwent aortic procedures including Ben-
tall (n¼ 7) or supra coronary ascending aortic replace-
ment (n¼ 8). Three patients were operated with an
acute type B-dissection. Two patients underwent an
emergency procedure because of aortic rupture.
The physical condition of the young Marfan
patients was much better as compared to the non-
Marfan group (Table 2). Apart from the age difference
(median age 40 versus 66 years) all co-morbid factors
were less present in the Marfan patients. Two Marfan
patients had preoperative renal failure, one of whom
was already on dialysis. Preoperative risk assessment
included echocardiography and myocardial perfusion
tests. Patients planned for arch replacement in addi-
tion to DTAA or TAAA repair requiring cardiac arrest
also underwent coronary arteriography.
The endpoints of the present study were postoper-
ative survival, short- and mid-term survival, freedom
of paraplegia/paraparesis or stroke, freedom of renal
failure and freedom of new or false arterial dilatation.Surgical Protocol
In all patients the same protocol was used. Intubation
is performed with a double-lumen endotracheal tube
or a selective left main bronchus blocker, enabling
Table 2. Preoperative data of the Marfan group compared with the
non-Marfan patients
Patients with
Marfan Syndrome
Non-Marfan
Patients
n 22 184
Median Age years 40 66
Median BMI 24 26
Obesity 4.5% 19.6%
Fev 1< 2l 4.5% 31.8%
COPD 4.5% 30.6%
Diabetes mellitus 0% 12.5%
Hyperlipoproteinemia 13.6% 43.5%
Myocardial infarction 4.5% 23.4%
Aortic valve insufficiency 18.2% 1.6%
Peripheral arterial disease 0% 19.1%
Renal insufficiency
(Creatinine> 1.2 mg/dl)
9% 26.6%
Arterial hypertension 81.8% 91.8%
Prior aortic dissection 100% 25.6%
Re-do procedure 68.1% 32.6%
BMI¼ Body mass index.
FEV1¼ Forced expiratory volume.
COPD¼Chronic obstructive pulmonary disease.
183TAAA Repair in Patients with Marfan Syndromecollapse of the left lung. Cerebrospinal fluid pressure
is assessed with an intrathecal catheter and main-
tained during the procedure and in the intensive
care unit until the third postoperative day. Cerebro-
spinal fluid is allowed to drain spontaneously if pres-
sure increases above 10 mmHg. Transcranial
electrical stimulation is performed to monitor motor
evoked potentials. This technique, which has been de-
scribed in detail,11e13 allows on-line assessment of
spinal cord function and guides the protective and
surgical strategies to prevent paraplegia. These strate-
gies include selective reattachment of intercostal and
lumbar arteries as well as blood pressure manage-
ment to maintain spinal cord integrity.
Patients are placed in a left helical position on a vac-
uum beanbag. A thoracolaparotomy through the sixth
intercostal space (eighth intercostal space in the pa-
tient with type IVaneurysm) is followed by limited in-
cision of the anterior diaphragm and opening of the
crus. In patients who required simultaneous aortic
arch replacement the fifth intercostal space was
opened. A loop around the diaphragm enables move-
ment of the diaphragm and exposes the aorta without
the necessity of completely transecting the muscle. Af-
ter limited heparinisation (0.5 mg/kg; ACT approxi-
mately 200 seconds), distal aortic perfusion is
established with cannulation of the left pulmonary
vein and the femoral artery using a centrifugal
pump. An arterial line is inserted in the contralateral
femoral artery. In the patient with type IV aneurysm,
a partial extracorporeal bypass graft is installed by
means of a femoral vein-femoral artery cannulation.In general, the aortic reconstruction is performed
from proximal to distal. However, in extensive
(chronic) type B aortic dissection involving the iliac
arteries we prefer to reverse the surgical direction be-
cause of the unpredictable changes in organ perfusion
with retrograde flow through dissected iliac arteries
and aorta. This is feasible if the infrarenal aorta can
be cross clamped temporarily. The aorto bi-iliac pros-
thesis is anastomosed distally first and subsequently
the main body is crossclamped and cannulated as ar-
terial inflow site. After starting extracorporeal circula-
tion, the aortic reconstruction is commenced with the
abdominal phase, followed by the thoracic segment.
The patient is allowed to cool to 32e33 degrees centi-
grade and actively rewarmed at the end of the proce-
dure. A 4-branched tubing system is connected to the
left-sided heart bypass, and four catheters with bal-
loon-inflatable tips are used for perfusion of the celiac
axis, superior mesenteric artery, and both renal ar-
teries. These perfusion catheters are equipped with
pressure channels, enabling pressure-controlled selec-
tive perfusion. Furthermore, in each catheter volume
flow is assessed with ultrasound flow meters. In
DTAA and type II TAAA the proximal cross-clamp
position depends on the extent of the aneurysm. In
any case, the aorta is completely freed from the esoph-
agus after transection of the ductus arteriosus. If the
shape of the thoracic descending aorta allows sequen-
tial cross-clamping, these positions are prepared. In
the abdomen the aorta is approached via the left retro-
colic and retrorenal access. After the left kidney is
tilted, the left renal artery is dissected and secured
with a vessel loop. After proximal cross-clamping,
transection of the aorta, and performance of the anas-
tomosis, distal aortic perfusion is maintained at
a mean pressure of 60 mmHg or higher. Based on
urine output (<15 ml per 15 minutes) and the ampli-
tude of motor evoked potentials, this arterial pressure
is increased, if necessary.
Since native aortic tissue is at risk for recurrent an-
eurysm formation in Marfan patients14 we try to re-
sect the aortic wall as much as possible, often
requiring individual grafts to the visceral and renal
arteries (Fig. 1). To avoid kinking, some grafts (espe-
cially the left renal artery bypass) are cut in sufficient
length to allow a loop-shaped position and anastomo-
sis in the aortic tube graft.
In the patients who suffered from associated arch
pathology, simultaneous arch replacement was per-
formed via the same surgical approach (left thoracot-
omy). The three patients requiring total arch
replacement already underwent previous ascending
graft implantation. Using total extra corporeal circula-
tion, including insertion of a left vent, the patient isEur J Vasc Endovasc Surg Vol 35, February 2008
Fig. 1. Intra-operative image of TAAA repair depicting
selective grafts to the visceral arteries and both renal
arteries. The bypass to the left renal artery is longer, allowing
a looped shape after repositioning the spleen, kidney and
intestines. (SMA¼ Superior mesenteric artery).
Table 3. Comparison of procedure related times between the
Marfan group and the non-Marfan patients
Patients with
Marfan’s syndrome
Non-Marfan patients
n 22 184
Median Duration of
procedure (minutes)
413 333
Min/max; sd 160/720; 122.43 150/720; 122.13
Median duration of
clamping (minutes)
109 84
Min/max; sd 40/527; 100.37 24/858; 95.25
Median perfusion time
(minutes)
180 128
Min/max; sd 60/486; 89.77 35/635; 70.91
184 G. Mommertz et al.cooled to 28 degrees centigrade. Subsequently, the de-
scending aorta is cross clamped and the arch opened.
A Foley catheter is inserted in the ascending aorta, the
balloon inflated graft and cardioplegia administered.
Meanwhile, antegrade cerebral perfusion is installed
by means of the same selective perfusion catheters
in the brachiocephalic and left carotid arteries. Total
antegrade cerebral flow is approximately 10 ml/kg/
min with a mean pressure of 60 mmHg. Using trans-
cranial Doppler and electroencephalography, cerebral
perfusion is continuously monitored in both
hemispheres.Results
The median operation time for the Marfan patients
was 413 minutes (160e720 minutes; sd: 122.43). Pa-
tient average cross clamp duration was 137 minutes
(40e527 minutes; sd: 100.37), the average duration
of left-heart bypass was 188 minutes (60e486 minutes;
sd: 89.76). The latter comprised installment of the se-
lective catheters in the supra-aortic arteries, separate
grafting of these vessels, reattachment of intercostal
arteries separate grafting to visceral and renal arteries,
distal anastomosis and reattachment of lumbar ar-
teries, if necessary. These different time intervals
were not significantly different when compared to
the non-Marfan patients (Table 3). In nearly 70% of
patients bypasses to visceral and renal arteries were
necessary, explaining the longer perfusion time since
all arteries are perfused during repair. In 18% of our
patients reattachment of intercostal arteries was ne-
seccary based on critically decreased amplitudes ofEur J Vasc Endovasc Surg Vol 35, February 2008motor evoked potentials. Peri-operative complications
were not encountered. During surgery and cross-
clamping, urine output was uninterrupted in all pa-
tients, irrespective of cross-clamp time. At the end of
the procedure, motor evoked potentials were ade-
quate in all patients.Major-complications
There were no intra-operative deaths and in-hospital
mortality did not occur. Visceral organ ischemia was
not encountered. There was no early, temporary or de-
layed paraplegia/paraparesis or stroke. Renal insuffi-
ciency did not occur. Mean pre-operative creatinine
level was 125 mmo/l, which peaked to a mean maxi-
mal level of 130 mmol/l and returned to 92 mmo/l at
discharge. Two patients already suffered from renal
failure before surgery due to aortic dissection and
subsequent renal artery compression but did not dete-
riorate after the procedure. In fact, one of the latter pa-
tients was on haemodialysis before surgery. Selective
bypass of both renal arteries improved renal function
and dialysis was not necessary anymore after the pro-
cedure. In the non-Marfan group (184 patients) major
complications occurred significantly more. Mortality
at 30 days was 12.4%, at 6 month 18.9% and at one
year 20.3%. Renal failure requiring temporary dialysis
occurred in three patients (1.6%) and permanent dial-
ysis in another three patients (1.6%). Early and de-
layed paraplegia was encountered in 2 (1.1%) and 4
(2.2%) patients respectively.Minor complications
Two patients (9%) developed pneumonia and one
patient showed evidence of respiratory distress syn-
drome. All three patients required prolonged ventila-
tory support. Median intubation time was 1.5 days
(0.33e30 days; sd: 8.46).
185TAAA Repair in Patients with Marfan SyndromeTwo patients had a persistent postoperative cardiac
arrhythmia but myocardial infarction was not encoun-
tered. In one patient surgical intervention was neces-
sary for postoperative bleeding.Recovery
The median duration of intensive care stay was 5 days
(1e45 days; sd: 12.21 days). The median intubation
time was 1.5 days in the Marfan group and 2 days
in the non-Marfan patients (Table 4). The median du-
ration of hospital stay was 24 days in the Marfan
group and 29.5 days in the non Marfan patients. At
a median follow-up of 38 months (2e72 months), all
patients were alive, free of reintervention and free of
haemodialysis. Surveillance CT-scanning revealed no
new or false aneurysms, except in one patient in
whom a visceral patch aneurysm was detected six
years after type II repair. All Marfan patients returned
to work and normal social life.Discussion
This clinical study demonstrates that open surgical re-
pair of thoracic and thoracoabdominal aortic aneu-
rysms in Marfan patients is associated with minimal
morbidity, absence of mortality and excellent late out-
come. In general, the results of open repair in degener-
ative thoracoabdominal aortic aneurysms have
improved significantly during the last two decades
due to developed protective modalities like distal aor-
tic perfusion, selective organ perfusion, cerebrospinal
fluid drainage and neuromonitoring.13,15,16 The largest
individual experience comprises 2286 patients with
TAAA with a mean age of 66.1 years.15 The majority
of these patients had degenerative aneurysms but
3.4% suffered from acute aortic dissection, 23.9%
from chronic dissection and 6.1% had a ruptured
TAAA. Using the multimodality approach, the overall
30-day survival was 95% and neurologic deficit andTable 4. Duration of intensive care, intubation and hospital stay
comparing the Marfan patients and the non-Marfan patients
Marfan patients Non-Marfan
patients
Median duration of
intensive care (days)
5 5
Min/max; sd 1/45; 12.28 0.1/55; 11.54
Median duration of
intubation (days)
1.5 2
Min/max; sd 0.33/30; 8.46 0.01/49; 9.56
Median duration of
hospital stay (days)
24 29.5
Min/max; sd 8/43; 9.73 2/61; 9.9renal failure occurred in 3.8% and 5.6%, respectively.
It should be emphasized that this center is a highly ex-
perienced and large volume hospital for TAAA repair.
The same colleagues reported on 137 patientswith con-
firmedMarfan syndrome and 163 with suspectedMar-
fan syndrome in which 398 procedures were
performed. Mean age of these patients was 39 years.
The 30-day mortality rate was 4.3% and freedom of re-
pair failure was significantly better in patients with
confirmed Marfan syndrome (90.3% at 10 years) than
in those with suspected Marfan syndrome (82.0% at
10 years; p¼ 0.001).17 Out of these 300 patients, 31 pa-
tients suffered from DTAA and 178 patients from
TAAA. Following open repair, operative mortality
rate was less than 6% and major complications in-
cluded renal failure (6%) and neurologic deficit (4%).
The authors concluded that operative treatment of aor-
tic pathology in Marfan patients provides excellent re-
sults and long-term survival. Recently, Kalkat et al.
reported on the surgical outcome of Marfan patients
with dissection and TAAA. Their number of patients
was comparable to our group and the results showed
similar outcome: no early mortality, renal failure and
paraplegia.18 Obviously, Marfan patients constitute
a group of younger age, which definitely adds to the
superior post operative outcome. Albornoz et al.19 ex-
amined the genetic nature and phenotypic features of
patientswith thoracic aortic aneurysms (TAA) and aor-
tic dissection and demonstrated an inherited pattern
for thoracic aneurysms in 22% of non-Marfan patients.
The familial TAA group was significantly younger
than the sporadic group, but not as young as the Mar-
fan patients (mean ages 58 versus 66 versus 27 years).
These age categories are rather similar to our patients
where the median age in the Marfan group was 40
years and in the non-Marfan group 64 years. In our
population, apart from age differences, the non-
Marfan patients with aortic disease suffered from
significantly more extensive co-morbidities including
hyperlipoproteinemia, obesity, impaired pulmonary
capacity, diabetes, myocardial infarction, peripheral
arterial disease, renal failure and hypertension.
A relevant question addresses the role of endo-
vascular treatment in Marfan patients with DTAA
and TAAA. Endovascular repair of degenerative ab-
dominal aortic aneurysms has become an established
minimal invasive modality. Also, treatment of athero-
sclerotic descending thoracic aneurysms, complicated
dissections, traumatic ruptures and false aneurysms
has progressively shifted from open to endovascular
correction. In addition, thoracoabdominal aneurysms
increasingly are managed by means of total endovas-
cular techniques or hybrid solutions in which the lat-
ter is characterised by debranching of major aorticEur J Vasc Endovasc Surg Vol 35, February 2008
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is obvious that these experimental interventions com-
prise enormous advantages with respect to surgical
trauma, however, longevity and durability of these
procedures still have to be proven. But what about
this treatment in Marfan patients? At present there is
little experience with stent-grafts in the thoracic aorta
of patients with Marfan syndrome. A small series
comprising six patients demonstrated at a mean fol-
low-up of over 51 months complete abolition of the
dissection and reconstruction of the entire dissected
aorta in only two patients, whereas elective conver-
sion to surgical repair was necessary in another two
patients and was considered in a third patient. One
patient died 12 months after endovascular repair.20
In patients with connective tissue disease the fria-
bility of the aortic wall can vary considerably and it
is unknown how the radial forces of stentgrafts will
interact on the long term. Retrograde dissection and
aortic perforation have already been encountered as
severe adverse events, even in non-Marfan patients.
Improved technology will solve these problems but
since long term results are not available yet we believe
that Marfan patients with aortic aneurysms should be
treated by open repair, preferably in centers of exper-
tise in which protective modalities as described above
are included in the surgical protocol. In patients with
recurrent aortic pathology, however, repeat sternot-
omy or thoracotomy could lead to increased surgical
risks like bleeding, cardiac injury, lung injury and in-
creased mortality. In these patients endovascular
treatment might induce less overall risks, worthwhile
to consider as an alternative solution.Conclusion
Surgical repair of descending and thoracoabdominal
aortic aneurysms provides excellent short- and mid-
term results in patients with Marfan syndrome. In
our experience, a surgical protocol with cerebrospinal
fluid drainage, distal and selective organ perfusion
and monitoring motor evoked potentials resulted in
low morbidity and absent mortality. These outcomes
and experience of others justify to consider open sur-
gery the gold-standard in Marfan patients with pri-
mary DTAA and TAAA. In the future endovascular
repair in Marfan patients can be considered if mid
and long-term assessment demonstrate similar
efficient and durable results. Complex DTAA and
TAAA procedures require adequate infrastructure
and a multidisciplinary team offering the entire spec-
trum of protectivemeasures to provide optimal results.Eur J Vasc Endovasc Surg Vol 35, February 2008References
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